The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma

Globally, hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death due to a lack of early predictive and/or diagnostic tools. Thus, research for a new biomarker is important. LncRNAs play a functional role in target gene regulation and their deregulation is associated w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2024-05, Vol.19 (5), p.e0303314-e0303314
Hauptverfasser: Golam, Rehab M, Khalil, Mahmoud A F, Shaker, Olfat G, Ahmed, Tarek I, Elguaad, Mohamed K Abd, Hassan, Essam A, El-Ansary, Mahmoud R M, Ismail, Ahmed, Kandil, Yasser I, Mohammed, Osama A, Doghish, Ahmed S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0303314
container_issue 5
container_start_page e0303314
container_title PloS one
container_volume 19
creator Golam, Rehab M
Khalil, Mahmoud A F
Shaker, Olfat G
Ahmed, Tarek I
Elguaad, Mohamed K Abd
Hassan, Essam A
El-Ansary, Mahmoud R M
Ismail, Ahmed
Kandil, Yasser I
Mohammed, Osama A
Doghish, Ahmed S
description Globally, hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death due to a lack of early predictive and/or diagnostic tools. Thus, research for a new biomarker is important. LncRNAs play a functional role in target gene regulation and their deregulation is associated with several pathological conditions including HCC. This study aimed to explore the diagnostic potential of two LncRNAs MALAT1 and CASC2 in HCC compared to the routinely used diagnostic biomarker. The current study is a case-control study carried out at Fayoum University Hospital and conducted on 89 individuals. The study included three groups of 36 HCC patients on top of HCV(HCC/HCV), 33 HCV patients, and 20 healthy volunteers as a control group. All study subjects were subjected to radiological examinations. The determination of CBC was performed by the automated counter and liver function tests by the enzymatic method were performed. In addition, HCV RNA quantification and the expression level of two LncRNAs (MALAT1 and CASC2) were performed by qRT-PCR. The results revealed a statistically significant difference between study groups regarding liver function tests with a higher mean in HCC/HCV group. Also, serum MALAT1 significantly up-regulated in HCV (11.2±2.8) and HCC/HCV (4.56±1.4) compared to the control group. Besides, serum CASC2 levels in the HCV group were significantly upregulated (14.9±3.6), while, downregulated in the HCC group (0.16± 0.03). Furthermore, The ROC analysis for diagnostic efficacy parameters indicated that CASC2 has higher accuracy (94.6%) and sensitivity (97.2%) for HCC diagnosis than AFP with an accuracy of (90.9%), sensitivity (69.4%), and MALAT1 showed an accuracy of (56.9%), sensitivity (72.2%). Our study results indicated that CASC2 is a promising biomarker and is considered better and could help in HCC diagnosis on top of HCV than MALAT1 and the routine biomarker AFP.
doi_str_mv 10.1371/journal.pone.0303314
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_3069288140</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A793631674</galeid><doaj_id>oai_doaj_org_article_40b7dfe270514fff825e523ebc264752</doaj_id><sourcerecordid>A793631674</sourcerecordid><originalsourceid>FETCH-LOGICAL-c642t-12d13d0e918c8d08c7252b8dc1408ad666e11681e784311f6f93a0770b3f61b03</originalsourceid><addsrcrecordid>eNqNk11v0zAUhiMEYqPwDxBEQkJwkeKP1HGuUFQBq1SYtJXdWo4_Uleu3cUJAvHncWg2NWgXyBc-sp_3PfaxT5K8hGAOcQE_7HzfOm7nB-_UHGCAMcwfJeewxCgjCODHJ_FZ8iyEHQALTAl5mpxhWuCSEHqe_N5sVSqscUZwmwbTOKNj6IRKvU6td03qvMuElyaGV9-qkH6t1tUGptzJdFldL1FqXNpFF2l443wwYVBeLG-yVlneKZlu1YF3Xihre8vbVPBWGOf3_HnyRHMb1ItxniXfP3_aLC-y9eWX1bJaZ4LkqMsgkhBLoEpIBZWAigItUE2lgDmgXBJCFISEQlXQHEOoiS4xB0UBaqwJrAGeJa-PvgfrAxvrFhgGpESURpdIrI6E9HzHDq3Z8_YX89ywvwu-bRhvOyOsYjmoC6kVKsAC5lprihZqgbCqBSJ5EaNZ8nHM1td7JYVyXcvtxHS648yWNf4HgxCUAMc3myXvRofW3_YqdGxvwlA-7pTvh4MvcpoDBIeDv_kHffh6I9XweAPjtI-JxWDKqqLEBENS5JGaP0DFIdXeiPjLtInrE8H7iSAynfrZNbwPga2ur_6fvbyZsm9P2K3ittsGb_vOeBemYH4ERetDaJW-rzIEbGiSu2qwoUnY2CRR9ur0he5Fd12B_wABOAmH</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3069288140</pqid></control><display><type>article</type><title>The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Public Library of Science (PLoS)</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Golam, Rehab M ; Khalil, Mahmoud A F ; Shaker, Olfat G ; Ahmed, Tarek I ; Elguaad, Mohamed K Abd ; Hassan, Essam A ; El-Ansary, Mahmoud R M ; Ismail, Ahmed ; Kandil, Yasser I ; Mohammed, Osama A ; Doghish, Ahmed S</creator><contributor>Bernardes de Jesus, Bruno</contributor><creatorcontrib>Golam, Rehab M ; Khalil, Mahmoud A F ; Shaker, Olfat G ; Ahmed, Tarek I ; Elguaad, Mohamed K Abd ; Hassan, Essam A ; El-Ansary, Mahmoud R M ; Ismail, Ahmed ; Kandil, Yasser I ; Mohammed, Osama A ; Doghish, Ahmed S ; Bernardes de Jesus, Bruno</creatorcontrib><description>Globally, hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death due to a lack of early predictive and/or diagnostic tools. Thus, research for a new biomarker is important. LncRNAs play a functional role in target gene regulation and their deregulation is associated with several pathological conditions including HCC. This study aimed to explore the diagnostic potential of two LncRNAs MALAT1 and CASC2 in HCC compared to the routinely used diagnostic biomarker. The current study is a case-control study carried out at Fayoum University Hospital and conducted on 89 individuals. The study included three groups of 36 HCC patients on top of HCV(HCC/HCV), 33 HCV patients, and 20 healthy volunteers as a control group. All study subjects were subjected to radiological examinations. The determination of CBC was performed by the automated counter and liver function tests by the enzymatic method were performed. In addition, HCV RNA quantification and the expression level of two LncRNAs (MALAT1 and CASC2) were performed by qRT-PCR. The results revealed a statistically significant difference between study groups regarding liver function tests with a higher mean in HCC/HCV group. Also, serum MALAT1 significantly up-regulated in HCV (11.2±2.8) and HCC/HCV (4.56±1.4) compared to the control group. Besides, serum CASC2 levels in the HCV group were significantly upregulated (14.9±3.6), while, downregulated in the HCC group (0.16± 0.03). Furthermore, The ROC analysis for diagnostic efficacy parameters indicated that CASC2 has higher accuracy (94.6%) and sensitivity (97.2%) for HCC diagnosis than AFP with an accuracy of (90.9%), sensitivity (69.4%), and MALAT1 showed an accuracy of (56.9%), sensitivity (72.2%). Our study results indicated that CASC2 is a promising biomarker and is considered better and could help in HCC diagnosis on top of HCV than MALAT1 and the routine biomarker AFP.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0303314</identifier><identifier>PMID: 38739668</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adult ; Aged ; Biology and life sciences ; Biomarkers ; Biomarkers, Tumor - blood ; Biomarkers, Tumor - genetics ; Blood ; Cancer ; Carcinoma, Hepatocellular - diagnosis ; Carcinoma, Hepatocellular - genetics ; Carcinoma, Hepatocellular - virology ; Case-Control Studies ; Clinical Relevance ; Deregulation ; Diagnosis ; Enzymes ; Ethylenediaminetetraacetic acid ; Female ; Females ; Gene expression ; Gene Expression Regulation, Neoplastic ; Gene regulation ; Genes ; Genetic aspects ; Health aspects ; Hemoglobin ; Hepacivirus - genetics ; Hepatitis B ; Hepatitis C - complications ; Hepatitis C - diagnosis ; Hepatitis C - genetics ; Hepatitis C - virology ; Hepatitis C virus ; Hepatocellular carcinoma ; Hepatoma ; Humans ; Infections ; Liver ; Liver cancer ; Liver Neoplasms - diagnosis ; Liver Neoplasms - genetics ; Liver Neoplasms - virology ; Male ; Medical diagnosis ; Medical research ; Medicine and Health Sciences ; MicroRNAs ; Middle Aged ; Non-coding RNA ; Parameter sensitivity ; Patients ; Phosphatase ; Proteins ; RNA ; RNA, Long Noncoding - blood ; RNA, Long Noncoding - genetics ; ROC Curve ; Sensitivity ; Statistical analysis ; Tumor Suppressor Proteins - genetics ; Ultrasonic imaging ; Variance analysis</subject><ispartof>PloS one, 2024-05, Vol.19 (5), p.e0303314-e0303314</ispartof><rights>Copyright: © 2024 Golam et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</rights><rights>COPYRIGHT 2024 Public Library of Science</rights><rights>2024 Golam et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2024 Golam et al 2024 Golam et al</rights><rights>2024 Golam et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c642t-12d13d0e918c8d08c7252b8dc1408ad666e11681e784311f6f93a0770b3f61b03</cites><orcidid>0000-0002-0136-7096</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11090319/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11090319/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,2096,2915,23847,27905,27906,53772,53774,79349,79350</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38739668$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Bernardes de Jesus, Bruno</contributor><creatorcontrib>Golam, Rehab M</creatorcontrib><creatorcontrib>Khalil, Mahmoud A F</creatorcontrib><creatorcontrib>Shaker, Olfat G</creatorcontrib><creatorcontrib>Ahmed, Tarek I</creatorcontrib><creatorcontrib>Elguaad, Mohamed K Abd</creatorcontrib><creatorcontrib>Hassan, Essam A</creatorcontrib><creatorcontrib>El-Ansary, Mahmoud R M</creatorcontrib><creatorcontrib>Ismail, Ahmed</creatorcontrib><creatorcontrib>Kandil, Yasser I</creatorcontrib><creatorcontrib>Mohammed, Osama A</creatorcontrib><creatorcontrib>Doghish, Ahmed S</creatorcontrib><title>The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Globally, hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death due to a lack of early predictive and/or diagnostic tools. Thus, research for a new biomarker is important. LncRNAs play a functional role in target gene regulation and their deregulation is associated with several pathological conditions including HCC. This study aimed to explore the diagnostic potential of two LncRNAs MALAT1 and CASC2 in HCC compared to the routinely used diagnostic biomarker. The current study is a case-control study carried out at Fayoum University Hospital and conducted on 89 individuals. The study included three groups of 36 HCC patients on top of HCV(HCC/HCV), 33 HCV patients, and 20 healthy volunteers as a control group. All study subjects were subjected to radiological examinations. The determination of CBC was performed by the automated counter and liver function tests by the enzymatic method were performed. In addition, HCV RNA quantification and the expression level of two LncRNAs (MALAT1 and CASC2) were performed by qRT-PCR. The results revealed a statistically significant difference between study groups regarding liver function tests with a higher mean in HCC/HCV group. Also, serum MALAT1 significantly up-regulated in HCV (11.2±2.8) and HCC/HCV (4.56±1.4) compared to the control group. Besides, serum CASC2 levels in the HCV group were significantly upregulated (14.9±3.6), while, downregulated in the HCC group (0.16± 0.03). Furthermore, The ROC analysis for diagnostic efficacy parameters indicated that CASC2 has higher accuracy (94.6%) and sensitivity (97.2%) for HCC diagnosis than AFP with an accuracy of (90.9%), sensitivity (69.4%), and MALAT1 showed an accuracy of (56.9%), sensitivity (72.2%). Our study results indicated that CASC2 is a promising biomarker and is considered better and could help in HCC diagnosis on top of HCV than MALAT1 and the routine biomarker AFP.</description><subject>Adult</subject><subject>Aged</subject><subject>Biology and life sciences</subject><subject>Biomarkers</subject><subject>Biomarkers, Tumor - blood</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Blood</subject><subject>Cancer</subject><subject>Carcinoma, Hepatocellular - diagnosis</subject><subject>Carcinoma, Hepatocellular - genetics</subject><subject>Carcinoma, Hepatocellular - virology</subject><subject>Case-Control Studies</subject><subject>Clinical Relevance</subject><subject>Deregulation</subject><subject>Diagnosis</subject><subject>Enzymes</subject><subject>Ethylenediaminetetraacetic acid</subject><subject>Female</subject><subject>Females</subject><subject>Gene expression</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Gene regulation</subject><subject>Genes</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Hemoglobin</subject><subject>Hepacivirus - genetics</subject><subject>Hepatitis B</subject><subject>Hepatitis C - complications</subject><subject>Hepatitis C - diagnosis</subject><subject>Hepatitis C - genetics</subject><subject>Hepatitis C - virology</subject><subject>Hepatitis C virus</subject><subject>Hepatocellular carcinoma</subject><subject>Hepatoma</subject><subject>Humans</subject><subject>Infections</subject><subject>Liver</subject><subject>Liver cancer</subject><subject>Liver Neoplasms - diagnosis</subject><subject>Liver Neoplasms - genetics</subject><subject>Liver Neoplasms - virology</subject><subject>Male</subject><subject>Medical diagnosis</subject><subject>Medical research</subject><subject>Medicine and Health Sciences</subject><subject>MicroRNAs</subject><subject>Middle Aged</subject><subject>Non-coding RNA</subject><subject>Parameter sensitivity</subject><subject>Patients</subject><subject>Phosphatase</subject><subject>Proteins</subject><subject>RNA</subject><subject>RNA, Long Noncoding - blood</subject><subject>RNA, Long Noncoding - genetics</subject><subject>ROC Curve</subject><subject>Sensitivity</subject><subject>Statistical analysis</subject><subject>Tumor Suppressor Proteins - genetics</subject><subject>Ultrasonic imaging</subject><subject>Variance analysis</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk11v0zAUhiMEYqPwDxBEQkJwkeKP1HGuUFQBq1SYtJXdWo4_Uleu3cUJAvHncWg2NWgXyBc-sp_3PfaxT5K8hGAOcQE_7HzfOm7nB-_UHGCAMcwfJeewxCgjCODHJ_FZ8iyEHQALTAl5mpxhWuCSEHqe_N5sVSqscUZwmwbTOKNj6IRKvU6td03qvMuElyaGV9-qkH6t1tUGptzJdFldL1FqXNpFF2l443wwYVBeLG-yVlneKZlu1YF3Xihre8vbVPBWGOf3_HnyRHMb1ItxniXfP3_aLC-y9eWX1bJaZ4LkqMsgkhBLoEpIBZWAigItUE2lgDmgXBJCFISEQlXQHEOoiS4xB0UBaqwJrAGeJa-PvgfrAxvrFhgGpESURpdIrI6E9HzHDq3Z8_YX89ywvwu-bRhvOyOsYjmoC6kVKsAC5lprihZqgbCqBSJ5EaNZ8nHM1td7JYVyXcvtxHS648yWNf4HgxCUAMc3myXvRofW3_YqdGxvwlA-7pTvh4MvcpoDBIeDv_kHffh6I9XweAPjtI-JxWDKqqLEBENS5JGaP0DFIdXeiPjLtInrE8H7iSAynfrZNbwPga2ur_6fvbyZsm9P2K3ittsGb_vOeBemYH4ERetDaJW-rzIEbGiSu2qwoUnY2CRR9ur0he5Fd12B_wABOAmH</recordid><startdate>20240513</startdate><enddate>20240513</enddate><creator>Golam, Rehab M</creator><creator>Khalil, Mahmoud A F</creator><creator>Shaker, Olfat G</creator><creator>Ahmed, Tarek I</creator><creator>Elguaad, Mohamed K Abd</creator><creator>Hassan, Essam A</creator><creator>El-Ansary, Mahmoud R M</creator><creator>Ismail, Ahmed</creator><creator>Kandil, Yasser I</creator><creator>Mohammed, Osama A</creator><creator>Doghish, Ahmed S</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0136-7096</orcidid></search><sort><creationdate>20240513</creationdate><title>The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma</title><author>Golam, Rehab M ; Khalil, Mahmoud A F ; Shaker, Olfat G ; Ahmed, Tarek I ; Elguaad, Mohamed K Abd ; Hassan, Essam A ; El-Ansary, Mahmoud R M ; Ismail, Ahmed ; Kandil, Yasser I ; Mohammed, Osama A ; Doghish, Ahmed S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c642t-12d13d0e918c8d08c7252b8dc1408ad666e11681e784311f6f93a0770b3f61b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biology and life sciences</topic><topic>Biomarkers</topic><topic>Biomarkers, Tumor - blood</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Blood</topic><topic>Cancer</topic><topic>Carcinoma, Hepatocellular - diagnosis</topic><topic>Carcinoma, Hepatocellular - genetics</topic><topic>Carcinoma, Hepatocellular - virology</topic><topic>Case-Control Studies</topic><topic>Clinical Relevance</topic><topic>Deregulation</topic><topic>Diagnosis</topic><topic>Enzymes</topic><topic>Ethylenediaminetetraacetic acid</topic><topic>Female</topic><topic>Females</topic><topic>Gene expression</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Gene regulation</topic><topic>Genes</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Hemoglobin</topic><topic>Hepacivirus - genetics</topic><topic>Hepatitis B</topic><topic>Hepatitis C - complications</topic><topic>Hepatitis C - diagnosis</topic><topic>Hepatitis C - genetics</topic><topic>Hepatitis C - virology</topic><topic>Hepatitis C virus</topic><topic>Hepatocellular carcinoma</topic><topic>Hepatoma</topic><topic>Humans</topic><topic>Infections</topic><topic>Liver</topic><topic>Liver cancer</topic><topic>Liver Neoplasms - diagnosis</topic><topic>Liver Neoplasms - genetics</topic><topic>Liver Neoplasms - virology</topic><topic>Male</topic><topic>Medical diagnosis</topic><topic>Medical research</topic><topic>Medicine and Health Sciences</topic><topic>MicroRNAs</topic><topic>Middle Aged</topic><topic>Non-coding RNA</topic><topic>Parameter sensitivity</topic><topic>Patients</topic><topic>Phosphatase</topic><topic>Proteins</topic><topic>RNA</topic><topic>RNA, Long Noncoding - blood</topic><topic>RNA, Long Noncoding - genetics</topic><topic>ROC Curve</topic><topic>Sensitivity</topic><topic>Statistical analysis</topic><topic>Tumor Suppressor Proteins - genetics</topic><topic>Ultrasonic imaging</topic><topic>Variance analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Golam, Rehab M</creatorcontrib><creatorcontrib>Khalil, Mahmoud A F</creatorcontrib><creatorcontrib>Shaker, Olfat G</creatorcontrib><creatorcontrib>Ahmed, Tarek I</creatorcontrib><creatorcontrib>Elguaad, Mohamed K Abd</creatorcontrib><creatorcontrib>Hassan, Essam A</creatorcontrib><creatorcontrib>El-Ansary, Mahmoud R M</creatorcontrib><creatorcontrib>Ismail, Ahmed</creatorcontrib><creatorcontrib>Kandil, Yasser I</creatorcontrib><creatorcontrib>Mohammed, Osama A</creatorcontrib><creatorcontrib>Doghish, Ahmed S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Golam, Rehab M</au><au>Khalil, Mahmoud A F</au><au>Shaker, Olfat G</au><au>Ahmed, Tarek I</au><au>Elguaad, Mohamed K Abd</au><au>Hassan, Essam A</au><au>El-Ansary, Mahmoud R M</au><au>Ismail, Ahmed</au><au>Kandil, Yasser I</au><au>Mohammed, Osama A</au><au>Doghish, Ahmed S</au><au>Bernardes de Jesus, Bruno</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2024-05-13</date><risdate>2024</risdate><volume>19</volume><issue>5</issue><spage>e0303314</spage><epage>e0303314</epage><pages>e0303314-e0303314</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Globally, hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death due to a lack of early predictive and/or diagnostic tools. Thus, research for a new biomarker is important. LncRNAs play a functional role in target gene regulation and their deregulation is associated with several pathological conditions including HCC. This study aimed to explore the diagnostic potential of two LncRNAs MALAT1 and CASC2 in HCC compared to the routinely used diagnostic biomarker. The current study is a case-control study carried out at Fayoum University Hospital and conducted on 89 individuals. The study included three groups of 36 HCC patients on top of HCV(HCC/HCV), 33 HCV patients, and 20 healthy volunteers as a control group. All study subjects were subjected to radiological examinations. The determination of CBC was performed by the automated counter and liver function tests by the enzymatic method were performed. In addition, HCV RNA quantification and the expression level of two LncRNAs (MALAT1 and CASC2) were performed by qRT-PCR. The results revealed a statistically significant difference between study groups regarding liver function tests with a higher mean in HCC/HCV group. Also, serum MALAT1 significantly up-regulated in HCV (11.2±2.8) and HCC/HCV (4.56±1.4) compared to the control group. Besides, serum CASC2 levels in the HCV group were significantly upregulated (14.9±3.6), while, downregulated in the HCC group (0.16± 0.03). Furthermore, The ROC analysis for diagnostic efficacy parameters indicated that CASC2 has higher accuracy (94.6%) and sensitivity (97.2%) for HCC diagnosis than AFP with an accuracy of (90.9%), sensitivity (69.4%), and MALAT1 showed an accuracy of (56.9%), sensitivity (72.2%). Our study results indicated that CASC2 is a promising biomarker and is considered better and could help in HCC diagnosis on top of HCV than MALAT1 and the routine biomarker AFP.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>38739668</pmid><doi>10.1371/journal.pone.0303314</doi><tpages>e0303314</tpages><orcidid>https://orcid.org/0000-0002-0136-7096</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2024-05, Vol.19 (5), p.e0303314-e0303314
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_3069288140
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Public Library of Science (PLoS); PubMed Central; Free Full-Text Journals in Chemistry
subjects Adult
Aged
Biology and life sciences
Biomarkers
Biomarkers, Tumor - blood
Biomarkers, Tumor - genetics
Blood
Cancer
Carcinoma, Hepatocellular - diagnosis
Carcinoma, Hepatocellular - genetics
Carcinoma, Hepatocellular - virology
Case-Control Studies
Clinical Relevance
Deregulation
Diagnosis
Enzymes
Ethylenediaminetetraacetic acid
Female
Females
Gene expression
Gene Expression Regulation, Neoplastic
Gene regulation
Genes
Genetic aspects
Health aspects
Hemoglobin
Hepacivirus - genetics
Hepatitis B
Hepatitis C - complications
Hepatitis C - diagnosis
Hepatitis C - genetics
Hepatitis C - virology
Hepatitis C virus
Hepatocellular carcinoma
Hepatoma
Humans
Infections
Liver
Liver cancer
Liver Neoplasms - diagnosis
Liver Neoplasms - genetics
Liver Neoplasms - virology
Male
Medical diagnosis
Medical research
Medicine and Health Sciences
MicroRNAs
Middle Aged
Non-coding RNA
Parameter sensitivity
Patients
Phosphatase
Proteins
RNA
RNA, Long Noncoding - blood
RNA, Long Noncoding - genetics
ROC Curve
Sensitivity
Statistical analysis
Tumor Suppressor Proteins - genetics
Ultrasonic imaging
Variance analysis
title The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T04%3A57%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20clinical%20significance%20of%20long%20non-coding%20RNAs%20MALAT1%20and%20CASC2%20in%20the%20diagnosis%20of%20HCV-related%20hepatocellular%20carcinoma&rft.jtitle=PloS%20one&rft.au=Golam,%20Rehab%20M&rft.date=2024-05-13&rft.volume=19&rft.issue=5&rft.spage=e0303314&rft.epage=e0303314&rft.pages=e0303314-e0303314&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0303314&rft_dat=%3Cgale_plos_%3EA793631674%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3069288140&rft_id=info:pmid/38739668&rft_galeid=A793631674&rft_doaj_id=oai_doaj_org_article_40b7dfe270514fff825e523ebc264752&rfr_iscdi=true